Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR New Investigator

McMaster University

$300,000.00

Immunometabolism of obesity and diabetes: Linking microbiota, immunity and metabolism

EF 2013-14

Résumé
The rise in type 2 diabetes is alarming. Pre-diabetes, can last for decades and is reversible, providing a chance to prevent the onset of diabetes. Once established, diabetes is currently incurable. Over half of Canadians are overweight, which is the most significant factor contributing to pre-diabetes. Obesity is associated with chronic inflammation, which is critical in causing pre-diabetes. The trigger for this inflammation during obesity is not clear. We have discovered that a part of the bacterial cell wall links inflammation and pre-diabetes during obesity. We have found that 2 different bacterial cell wall sensors are involved. We discovered that one bacterial sensor promotes pre-diabetes during obesity, but the other is actually protective. These bacterial sensors regulate the type bacteria in our gut and how some of these bacteria can get inside our bodies and invade into the surrounding fat tissue or liver. These changes in bacteria are a potential trigger causing inflammation during obesity. This research program studies how the trillions of bacteria that live in our gut are changed by our genes, what we eat and drugs that we take (such as antibiotics) when we get sick. This provides a new way to search for bacterial and inflammatory causes of pre-diabetes. This is important because it is not yet understood why only certain obese individuals develop pre-diabetes, whereas others are metabolically healthy. This work can enhance the identification of people that are susceptible to diabetes by finding bacterial and inflammation markers of disease. This research will help direct new diet interventions including specific prebiotics and probiotics and may identify new therapies that could prevent type 2 diabetes. This work may direct changes in the monitoring or care of obese patients with gut diseases and/or diabetes and alter clinical practice of antibiotic use.
Programme
CIHR New Investigator
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
301865
Name
Schertzer Jonathan D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
New Investigators A
Projecttitle
Immunometabolism of obesity and diabetes: Linking microbiota, immunity and metabolism
Programtype2
Salary Programs
Orgnameinp2
McMaster University
Cihramount2
$300,000
Cihrequipment2
$0
Programname2
CIHR New Investigator
Keyworddelim
Fat Metabolism; Glucose Metabolism; Immunity; Insulin Resistance; Metabolic Inflammation; Microbiome; Pattern Recognition Receptors; Type 2 Diabetes
Abstract
The rise in type 2 diabetes is alarming. Pre-diabetes, can last for decades and is reversible, providing a chance to prevent the onset of diabetes. Once established, diabetes is currently incurable. Over half of Canadians are overweight, which is the most significant factor contributing to pre-diabetes. Obesity is associated with chronic inflammation, which is critical in causing pre-diabetes. The trigger for this inflammation during obesity is not clear. We have discovered that a part of the bacterial cell wall links inflammation and pre-diabetes during obesity. We have found that 2 different bacterial cell wall sensors are involved. We discovered that one bacterial sensor promotes pre-diabetes during obesity, but the other is actually protective. These bacterial sensors regulate the type bacteria in our gut and how some of these bacteria can get inside our bodies and invade into the surrounding fat tissue or liver. These changes in bacteria are a potential trigger causing inflammation during obesity. This research program studies how the trillions of bacteria that live in our gut are changed by our genes, what we eat and drugs that we take (such as antibiotics) when we get sick. This provides a new way to search for bacterial and inflammatory causes of pre-diabetes. This is important because it is not yet understood why only certain obese individuals develop pre-diabetes, whereas others are metabolically healthy. This work can enhance the identification of people that are susceptible to diabetes by finding bacterial and inflammation markers of disease. This research will help direct new diet interventions including specific prebiotics and probiotics and may identify new therapies that could prevent type 2 diabetes. This work may direct changes in the monitoring or care of obese patients with gut diseases and/or diabetes and alter clinical practice of antibiotic use.
Competitiondate
201312
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Schertzer, Jonathan D
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $300,000~ $0~